ArticleInternational journal of retina and vitreous2024
Evaluating photodynamic therapy versus brolucizumab as a second-line treatment for polypoidal choroidal vasculopathy.
Ryoh Funatsu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.